Injective, a blockchain platform based on Cosmos, is making significant strides in the crypto market despite recent underperformance. The platform plans to launch a layer-3 network on Arbitrum, enhancing its presence in the Ethereum ecosystem. This expansion is complemented by the introduction of the CW-404 standard, which enables fractional ownership of NFTs, broadening financial use cases and accessibility. Additionally, Canary Capital's filing for a staked Injective ETF highlights growing institutional interest in Injective, potentially positioning it alongside other major staked crypto ETFs like Solana and Ether.
These developments underscore Injective's commitment to innovation and adaptability in the rapidly evolving DeFi landscape. The launch of its mainnet with a $120 million incentive program further demonstrates its proactive approach to attracting users and developers. As the platform continues to integrate advanced technologies and explore new financial products, it aims to solidify its role as a key player in the future of decentralized finance.
Injective (INJ): A Deep Dive into Blockchain Expansion and Innovation
September 25, 2025
1 min read
Injective, a blockchain platform based on Cosmos, is making significant strides in the crypto market despite recent underperformance. The platform plans to launch a layer-3 network on Arbitrum, enhancing its presence in the Ethereum ecosystem. This expansion is complemented by the introduction of the CW-404 standard, which enables fractional ownership of NFTs, broadening financial use cases and accessibility.